Specificity | Clone | Host Species | Reactive Species | Format | Size | |
---|---|---|---|---|---|---|
Adalimumab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg; 25 mg; 50 mg | More Info |
Atezolizumab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg; 25 mg; 50 mg | More Info |
Avelumab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg; 10 mg | More Info |
Benralizumab | monoclonal | Humanized | n/a | unconjugated | 1 mg; 2 mg | More Info |
Bevacizumab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg; 25 mg; 50 mg | More Info |
Camrelizumab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg | More Info |
Cetuximab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg; 25 mg; 50 mg | More Info |
Daratumumab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg | More Info |
Disitamab vedotin | monoclonal | n/a | n/a | MMAE conjugate | 1 mg; 5 mg | More Info |
Dupilumab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg | More Info |
Durvalumab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg; 25 mg; 50 mg | More Info |
Ipilimumab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg; 25 mg; 50 mg | More Info |
MERS-3A1 | monoclonal | Human | n/a | unconjugated | 100 µg; 500 µg | More Info |
MERS-D12 | monoclonal | Human | n/a | unconjugated | 500 µg; 100 µg | More Info |
MERS-2E6 | monoclonal | Human | n/a | unconjugated | 100 µg; 500 µg | More Info |
Natalizumab | monoclonal | Humanized | n/a | unconjugated | 10 mg; 25 mg | More Info |
Nimotuzumab | monoclonal | Humanized | n/a | unconjugated | 1 mg; 5 mg | More Info |
Nivolumab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg; 25 mg; 50 mg | More Info |
Obinutuzumab | monoclonal | Humanized | n/a | unconjugated | 1 mg; 5 mg; 25 mg; 50 mg | More Info |
Omalizumab | monoclonal | Humanized | n/a | unconjugated | 1 mg; 5 mg | More Info |
Pembrolizumab | monoclonal | Humanized | n/a | unconjugated | 1 mg; 5 mg; 25 mg; 50 mg | More Info |
Pertuzumab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg; 25 mg; 50 mg | More Info |
Ranibizumab | monoclonal | Humanized | n/a | unconjugated | 1 mg | More Info |
Reslizumab | monoclonal | Humanized | n/a | unconjugated | 1 mg; 2 mg | More Info |
Rituximab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg; 25 mg; 50 mg | More Info |
Sarilumab | monoclonal | Human | n/a | unconjugated | n/a | More Info |
SARS-CoV-2 Spike (CR3022) | monoclonal | Human | n/a | unconjugated | 100 µg; 500 µg | More Info |
SARS-80R | monoclonal | Human | n/a | unconjugated | 100 µg; 500 µg | More Info |
Secukinumab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg | More Info |
Spike-RBD | monoclonal | Human | n/a | unconjugated | 100 µg; 500 µg | More Info |
Spike-RBD Single Domain | monoclonal | Alpaca | n/a | VHH single domain | 100 µg; 500 µg | More Info |
Tocilizumab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg; 25 mg | More Info |
Trastuzumab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg; 25 mg; 50 mg | More Info |
Trastuzumab emtansine | monoclonal | human | n/a | DM1 conjugate | 1 mg; 5 mg; 10 mg | More Info |
Ustekinumab | monoclonal | Human | n/a | unconjugated | 1 mg; 5 mg; 25 mg; 50 mg | More Info |
Vedolizumab | monoclonal | Humanized | n/a | unconjugated | 1 mg; 5 mg; 25 mg; 50 mg | More Info |